Showing results (11-20 of 516) with videos related to
Sort By:
Pageof 52
Breast Cancer Research and Treatment|March 7, 2024
Intertumoral heterogeneity of bifocal breast cancer: a morphological and molecular studyKai Finsterbusch, Paul J van Diest, Cornelia M FockeBMC Family Practice|January 30, 2007
Value of histopathologic analysis of subcutis excisions by general practitionersPieter A J Buis, Wim Verweij, Paul J van DiestHistopathology|May 6, 2015
Tracing differences between male and female breast cancer: both diseases own a different biologyRobert Kornegoor, Paul J van Diest, Horst Buerger, et al.Toxicologic Pathology|September 28, 2025
Toxicologic Pathology Forum*: Opinion on the Future of Histopathology Using Whole Slide Images in Toxicologic Pathology of Preclinical Studies and Its Successful Implementation in Compliance With Good Laboratory Practice-Yes, We Are There!Bob Thoolen, Alys Bradley, Nikolas Stathonikos, et al.Journal of Pathology Informatics|November 26, 2015
Working toward consensus among professionals in the identification of classical cervical cytomorphological characteristics in whole slide imagesOdille Bongaerts, Paul J van Diest, Math Pieters, et al.Journal of Pathology Informatics|July 17, 2013
Going fully digital: Perspective of a Dutch academic pathology labNikolas Stathonikos, Mitko Veta, André Huisman, et al.Biochimica Et Biophysica Acta. Reviews on Cancer|October 3, 2017
Targeting RNA helicases in cancer: The translation trapMarise R Heerma van Voss, Paul J van Diest, Venu RamanApplied Immunohistochemistry & Molecular Morphology : AIMM|December 13, 2016
Performance of 4 Immunohistochemical Phosphohistone H3 Antibodies for Marking Mitotic Figures in Breast CancerCornelia M Focke, Kai Finsterbusch, Thomas Decker, et al.Virchows Archiv : an International Journal of Pathology|August 6, 2017
Correlation between E-cadherin and p120 expression in invasive ductal breast cancer with a lobular component and MRI findingsMary-Ann El Sharouni, Emily L Postma, Paul J van DiestBreast Cancer Research and Treatment|September 18, 2009
Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplificationCathy B Moelans, Roel A de Weger, Paul J van DiestPageof 52